Atrial Natriuretic Peptide (ANP), rat: Mechanism, Evidence & Research Use

Executive Summary: Atrial Natriuretic Peptide (ANP), rat is a 28-amino-acid peptide hormone with a molecular formula of C₄₉H₈₄N₂₀O₁₅S and a molecular weight of 1225.38 Da (APExBIO, 2024). It is synthesized and secreted by atrial myocytes in response to atrial stretch and neurohormonal stimuli. ANP acts as a potent vasodilator, modulating water, sodium, potassium, and adipose tissue homeostasis (https://atrial-natriuretic-factor.com/index.php?g=Wap&m=Article&a=detail&id=43). By promoting natriuresis and lowering systemic blood pressure, ANP is widely used in cardiovascular, renal, and metabolic research. APExBIO provides high-purity ANP (SKU A1009) with validated HPLC and mass spectrometry benchmarks for reproducible experimental outcomes.

Biological Rationale

Atrial Natriuretic Peptide (ANP), rat is an endogenous peptide hormone secreted by cardiac atrial myocytes. Its primary physiological roles include regulating extracellular fluid volume, sodium excretion (natriuresis), and vascular tone. ANP is released upon atrial distension, increased blood volume, or activation by agents such as angiotensin II, endothelin, or sympathetic nervous system signals. The hormone counteracts the renin-angiotensin-aldosterone system (RAAS) and inhibits vasopressin secretion, thus promoting diuresis and natriuresis. ANP also acts on adipose tissue, influencing lipid metabolism and energy balance (https://bnp1-32.com/index.php?g=Wap&m=Article&a=detail&id=15902). These properties make ANP a critical molecular tool for dissecting cardiovascular and renal mechanisms and for developing antihypertensive strategies in preclinical research.

Mechanism of Action of Atrial Natriuretic Peptide (ANP), rat

ANP exerts its biological effects by binding to the natriuretic peptide receptor-A (NPR-A), a membrane-bound guanylate cyclase receptor. Upon ligand binding, there is an increase in intracellular cyclic guanosine monophosphate (cGMP), which mediates smooth muscle relaxation and vasodilation. The downstream effects include:

• Inhibition of sodium reabsorption in the distal nephron of the kidney, increasing sodium and water excretion (natriuresis and diuresis).
• Suppression of renin and aldosterone secretion, further reducing blood volume and pressure.
• Direct vasodilatory actions on vascular smooth muscle.
• Modulation of adipocyte metabolism, including inhibition of lipolysis and regulation of adiponectin secretion (see reference on adiponectin, Zhang et al. 2022).

Through these mechanisms, ANP is a central regulator of blood pressure and fluid-electrolyte homeostasis.

Evidence & Benchmarks

• ANP (rat) increases sodium excretion by 50–150% in Sprague Dawley rats at doses of 10–100 μg/kg i.v. (https://atrial-natriuretic-factor.com/index.php?g=Wap&m=Article&a=detail&id=43).
• Exposure to 10 nM ANP in vitro leads to a 2–3 fold rise in cGMP in cultured rat mesangial cells (https://sitagliptinphosphate.com/index.php?g=Wap&m=Article&a=detail&id=15899).
• APExBIO’s A1009 ANP has a verified purity of 95.92% (HPLC, MS), enabling reproducible data in cardiovascular models (product page).
• ANP-mediated vasodilation reduces mean arterial pressure by 10–30 mmHg in rat models within 30 minutes post-administration (https://bnp1-32.com/index.php?g=Wap&m=Article&a=detail&id=15902).
• Adiponectin and ANP signaling are linked in adipose tissue metabolic regulation, supporting translational neuroendocrine research (Zhang et al. 2022).

This article supplements 'Atrial Natriuretic Peptide (ANP), Rat: Mechanisms, Models...' by providing new quantitative benchmarks and clarifying the peptide’s role in neuroimmune-metabolic crosstalk in rat models.

Applications, Limits & Misconceptions

ANP, rat is widely used in:

• Cardiovascular research: Studying blood pressure homeostasis and heart failure mechanisms.
• Renal physiology: Probing natriuretic responses and renal hemodynamics.
• Metabolic studies: Investigating adipose tissue metabolism and adiponectin regulation.
• Translational models: Evaluating therapeutic interventions for hypertension and metabolic syndrome.

For detailed laboratory protocols, see 'Atrial Natriuretic Peptide: Advanced Cardiovascular Research...'; this article updates that guide by integrating new purity and workflow metrics specific to APExBIO's A1009 formulation.

Common Pitfalls or Misconceptions

• ANP is not effective in ethanol-based solvents due to insolubility; use DMSO or water for stock solutions at ≥122.5 mg/mL and ≥43.5 mg/mL, respectively (APExBIO).
• Long-term storage of ANP solutions reduces bioactivity; prepare fresh aliquots and store lyophilized peptide at -20°C only.
• ANP does not replace standard antihypertensive therapies in clinical settings; it is strictly for experimental use.
• Species-specific effects: Rat ANP may not fully recapitulate human physiology in translational studies.
• Over-reliance on single-dose data may lead to misinterpretation; always use appropriate controls and dose ranges.

Workflow Integration & Parameters

For optimal results, ANP (SKU A1009) from APExBIO should be reconstituted at ≥122.5 mg/mL in DMSO or ≥43.5 mg/mL in water. The peptide is supplied as a solid and should be stored at -20°C. Purity is confirmed by HPLC and MS (95.92%). Use freshly prepared solutions for experimental protocols to maintain biological activity. Applicable dose ranges for in vivo infusion in rats typically span 10–100 μg/kg, with careful monitoring of hemodynamic and renal endpoints. For cell-based assays, 1–100 nM is a common working concentration for cGMP response evaluation. For troubleshooting and advanced use cases, see 'Atrial Natriuretic Peptide (ANP), rat: Reliable Experimental…'; this article extends those recommendations with new purity and storage guidance.

Conclusion & Outlook

Atrial Natriuretic Peptide (ANP), rat from APExBIO provides a validated, high-purity tool for dissecting mechanisms of vasodilation, natriuresis, and metabolic regulation in preclinical research. Its well-characterized action on NPR-A and robust benchmarks make it a reference standard for studies in blood pressure regulation and renal physiology. Future research will clarify additional neuroimmune and adipose tissue roles, as suggested by recent work on adiponectin and inflammatory signaling (Zhang et al. 2022).